Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Viral Vaccines (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Viral Vaccines (supply & distribution) < Viral Vaccines (therapeutic use) < Viral Vaccines (toxicity)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000494 (2003) Wentao Gao [États-Unis] ; Azaibi Tamin [États-Unis] ; Adam Soloff [États-Unis] ; Leonardo D'Aiuto [États-Unis] ; Edward Nwanegbo [États-Unis] ; Paul D. Robbins [États-Unis] ; William J. Bellini [États-Unis] ; Simon Barratt-Boyes [États-Unis] ; Andrea Gambotto [États-Unis]Effects of a SARS-associated coronavirus vaccine in monkeys
000580 (2003) Elena Armandola [Allemagne]Conference report - II. Investigating new vaccines: SARS. Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.
000830 (2004) Denong Wang [États-Unis] ; Jiahai LuGlycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV.
000E04 (2005) John S. Oxford [Royaume-Uni] ; Shobana Balasingam ; Charlotte Chan ; Andrew Catchpole ; Robert LambkinNew antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.
001121 (2005) Konrad Stadler ; Anjeanette Roberts ; Stephan Becker ; Leatrice Vogel ; Markus Eickmann ; Larissa Kolesnikova ; Hans-Dieter Klenk ; Brian Murphy ; Rino Rappuoli ; Sergio Abrignani ; Kanta SubbaraoSARS vaccine protective in mice.
001302 (2005) Susan R. Weiss ; Sonia Navas-MartinCoronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
001470 (2006) Yeou-Ping Tsao ; Jian-Yu Lin [Taïwan] ; Jia-Tsrong Jan [Taïwan] ; Chih-Hsiang Leng [Taïwan] ; Chen-Chung Chu [Taïwan] ; Yuh-Cheng Yang [Taïwan] ; Show-Li Chen [Taïwan]HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins
001787 (2007) Hongliang Wang [République populaire de Chine] ; Shuan Rao ; Chengyu JiangMolecular pathogenesis of severe acute respiratory syndrome.
001806 (2006) Gerhard Hoheisel [Allemagne] ; Wei Kwang Luk ; Jörg Winkler ; Adrian Gillissen ; Hubert Wirtz ; Uwe Gerd Liebert ; David S. Hui[Severe acute respiratory syndrome (SARS)].
001894 (2007) Kap-Sun Yeung [États-Unis] ; Nicholas A. MeanwellRecent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
001A94 (2007) Alison Bermingham [Royaume-Uni] ; Kelly Henrickson ; Frederick Hayden ; Maria ZambonVII International Symposium on Respiratory Viral Infections.
001B62 (2007) Shumei Zhai [République populaire de Chine] ; Wei Liu ; Bing YanRecent patents on treatment of severe acute respiratory syndrome (SARS).
001B79 (2008) Enid T. Mckinley [États-Unis] ; Deborah A. Hilt ; Mark W. JackwoodAvian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination.
001E44 (2008) Pravin K. Bhatnagar ; Dipankar Das ; Mavanur R. SureshMolecular Targets for Diagnostics and Therapeutics of Severe Acute Respiratory Syndrome (SARS-CoV)
002389 (2011) Meagan Bolles [États-Unis] ; Damon Deming [États-Unis] ; Kristin Long [États-Unis] ; Sudhakar Agnihothram [États-Unis] ; Alan Whitmore [États-Unis] ; Martin Ferris [États-Unis] ; William Funkhouser [États-Unis] ; Lisa Gralinski [États-Unis] ; Allison Totura [États-Unis] ; Mark Heise [États-Unis] ; Ralph S. Baric [États-Unis]A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge▿
002720 (2013) Vathan Kumar ; Young-Sik Jung ; Po-Huang LiangAnti-SARS coronavirus agents: a patent review (2008 - present).
002E43 (2017) Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Alahmed [Arabie saoudite] ; Ali M. Bazzi [Arabie saoudite] ; Hatem M. Alhani [Arabie saoudite]A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective.
003100 (2020) Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon]Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
003412 (2020) Shibo JiangDon't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Viral Vaccines (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Viral Vaccines (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Viral Vaccines (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021